SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Nakamoto Inc. (NAKA)
Score window: May. 30, 2025 to May. 29, 2026

Probe Score
6.5 / 10
Letters
3
Latest Activity
Feb. 26, 2026
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
1.0
Signals
0.0
Notable 8-K Modifier
1.0
Notable 8-K Count
4

Matched Signals

enforcement

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Apr. 21, 2026 CORRESP Neutral/Informational Moderate Nakamoto Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. The company aims for the statement to be declared ef… Read Filing EDGAR
Apr. 21, 2026 CORRESP Neutral/Informational Moderate Nakamoto Inc. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3. They are seeking to have it declared effective by Ap… Read Filing EDGAR
Apr. 16, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Nakamoto Inc. that it will not review their registration statement filed on April 9, 2026. This indicates that the responsibility for the accuracy and … Read Filing EDGAR
Apr. 16, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Nakamoto Inc. that they will not review the company's registration statement filed on April 9, 2026. The letter emphasizes that the responsibility for … Read Filing EDGAR
Jul. 21, 2025 UPLOAD Neutral/Informational Low The SEC has completed its review of Kindly MD, Inc.'s Revised Information Statement on Schedule 14C, filed on July 18, 2025. The correspondence emphasizes that the responsibility … Read Filing EDGAR
Jul. 18, 2025 CORRESP Neutral/Informational Moderate Nakamoto Inc. has submitted a response to the SEC's comment letter regarding their revised preliminary information statement on Schedule 14C. The SEC raised several concerns about… Read Filing EDGAR
Jul. 16, 2025 UPLOAD Concern from SEC High The SEC has reviewed Kindly MD, Inc.'s revised Information Statement on Schedule 14C and provided several comments that require attention. Key areas of concern include the need fo… Read Filing EDGAR
Jul. 11, 2025 CORRESP Concern from SEC Moderate The correspondence from Nakamoto Inc. addresses comments from the SEC regarding their preliminary information statement on Schedule 14C filed by KindlyMD, Inc. The SEC raised conc… Read Filing EDGAR
Jul. 9, 2025 UPLOAD Concern from SEC High The SEC has reviewed Kindly MD, Inc.'s Information Statement on Schedule 14C and has raised several comments that require clarification. Key issues include discrepancies in the vo… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.